Live Breaking News & Updates on Hedge Funds Weigh In On Ionis Pharmaceuticals|Page 2

Stay updated with breaking news from Hedge funds weigh in on ionis pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Rating of "Moderate Buy" by Brokerages

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Rating of "Moderate Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , William Blair , Eugene Schneider , Stifel Nicolaus , B Lynne Parshall , News Ratings For Ionis Pharmaceuticals Daily , Securities Exchange Commission , Hedge Funds Weigh In On Ionis Pharmaceuticals , Ionis Pharmaceuticals , Ionis Pharmaceuticals Stock , California Public Employees Retirement System , Analyst Recommendations For Ionis Pharmaceuticals , Charles Schwab Investment Management Inc , Ionis Pharmaceuticals Inc , Ionis Pharmaceuticals Company Profile , Campbell Co Investment Adviser , Royal Bank , Sg Americas Securities , Get Free Report , Directorb Lynne Parshall , Exchange Commission , Nova Scotia , Schwab Investment Management , Public Employees Retirement System , Get Free ,

Ionis Pharmaceuticals (NASDAQ:IONS) Announces Quarterly Earnings Results

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.72, MarketWatch Earnings reports. The company had revenue of $325.00 million during the quarter, compared to analysts’ expectations of $176.01 million. Ionis Pharmaceuticals had […] ....

United States , Elizabethl Hougen , Stifel Nicolaus , Earnings History For Ionis Pharmaceuticals , Raymond James Financial Services Advisors Inc , News Ratings For Ionis Pharmaceuticals Daily , Hedge Funds Weigh In On Ionis Pharmaceuticals , American Century Companies Inc , Ionis Pharmaceuticals Stock Performance , Ionis Pharmaceuticals Inc , Metlife Investment Management , Jpmorgan Chase Co , Ionis Pharmaceuticals , Financial Services Group Inc , Us Bancorp , Morgan Stanley , Get Free Report , Marketwatch Earnings , James Financial Services Advisors , Century Companies , Services Group , Ionis Pharmaceuticals Daily , Nasdaq Ions ,

Ionis Pharmaceuticals (IONS) to Release Quarterly Earnings on Wednesday

Ionis Pharmaceuticals (IONS) to Release Quarterly Earnings on Wednesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , B Lynne Parshall , Almanack Investment Partners , Ionis Pharmaceuticals Stock Performance , Goldman Sachs Group , Ionis Pharmaceuticals Inc , Securities Exchange Commission , News Ratings For Ionis Pharmaceuticals Daily , Royal Bank , Comerica Bank , Quilter Plc , Hedge Funds Weigh In On Ionis Pharmaceuticals , Morgan Stanley , Ionis Pharmaceuticals , Earnings History For Ionis Pharmaceuticals , Get Free Report , Directorb Lynne Parshall , Exchange Commission , Investment Partners , Captrust Financial Advisors , Financial Advisors , Ionis Pharmaceuticals Daily ,

Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price Down 4.5%

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares traded down 4.5% during mid-day trading on Thursday . The stock traded as low as $46.84 and last traded at $46.85. 1,400,503 shares were traded during trading, an increase of 23% from the average session volume of 1,139,582 shares. The stock had previously closed at $49.07. […] ....

United States , Piper Sandler , Needham Company , Midwest Professional Planners , Securities Exchange Commission , Chartwell Investment Partners , Voloridge Investment Management , Ionis Pharmaceuticals Company Profile , Insider Activity At Ionis Pharmaceuticals , Ionis Pharmaceuticals Trading Down , Capital Partners , Hedge Funds Weigh In On Ionis Pharmaceuticals , Ionis Pharmaceuticals , News Ratings For Ionis Pharmaceuticals Daily , Morgan Stanley , Ionis Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Trading Down , Exchange Commission , Employees Retirement System , Investment Partners , Professional Planners , Ionis Pharmaceuticals Daily , Nasdaq Ions ,

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) EVP Eric Swayze Sells 10,773 Shares

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Eric Swayze sold 10,773 shares of the stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $52.00, for a total transaction of $560,196.00. Following the transaction, the executive vice president now owns 32,516 shares in the company, valued […] ....

United States , New Jersey , Eric Swayze , Stifel Nicolaus , Needham Company , Quarter For Ionis Pharmaceuticals , Ionis Pharmaceuticals , News Ratings For Ionis Pharmaceuticals Daily , Goldman Sachs Group , Truist Financial Corp , Ionis Pharmaceuticals Inc , Hedge Funds Weigh In On Ionis Pharmaceuticals , Ltd Zurich , Jpmorgan Chase Co , Ionis Pharmaceuticals Company Profile , Bank Julius Baer Co , Ionis Pharmaceuticals Trading Down , Jersey Common Pension Fund , Get Free Report , Pharmaceuticals Trading Down , Financial Corp , Julius Baer , Handelsbanken Fonder , Ionis Pharmaceuticals Daily , Nasdaq Ions , Insider Trading ,